Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors

Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, USA.
Journal of Medicinal Chemistry (Impact Factor: 5.45). 10/2007; 50(18):4351-73. DOI: 10.1021/jm070034i
Source: PubMed


Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers. Guided by X-ray crystallography and molecular modeling, a series of 2-aminobenzimidazoles and 2-aminobenzoxazoles were identified as potent inhibitors of VEGFR-2 (KDR) in both enzymatic and HUVEC cellular proliferation assays. In this report we describe the synthesis and structure-activity relationship of a series of 2-aminobenzimidazoles and benzoxazoles, culminating in the identification of benzoxazole 22 as a potent and selective VEGFR-2 inhibitor displaying a good pharmacokinetic profile. Compound 22 demonstrated efficacy in both the murine matrigel model for vascular permeability (79% inhibition observed at 100 mg/kg) and the rat corneal angiogenesis model (ED(50) = 16.3 mg/kg).

6 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of novel N-methylpicolinamide-moiety containing diarylthiosemicarbazide derivatives was prepared and evaluated for their in vitro antiproliferative activity against three cancer cell lines(human alveolar epithelial cell A549, human lung cancer cell H460 and human colorectal cancer cell HT-29) by 3-(4,5-dimethyl)thiazolyl-diphenyltetrazoliumromide(MTT) assay. Six compounds(7b–7g) with halogen substituents exhibited preferable cytotoxicity against one or more cell lines in a low micromolar range. Especially, the most promising compound 7g exhibited remarkable antiproliferative activity with the IC50 values of 2.2, 1.8 and 5.2 μmol/L against A549, H460 and HT-29 cell lines respectively, which is comparable to sorafenib.
    Chemical Research in Chinese Universities 02/2013; 29(1). DOI:10.1007/s40242-013-2136-5 · 0.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of novel sorafenib derivatives containing diaryl thiourea and thioether, 9a–u, was designed and synthesized, and their antiproliferative activities against HCT116 and MDA-MB-231 cell lines were also evaluated and described. Most compounds exhibited potent antiproliferative activity against HCT116 cells with IC50 = 1.8–80.4 μM. Compounds 9p, 9r, and 9s demonstrated competitive antiproliferative activities to sorafenib, against all two cancer cell lines. The structures of all the newly synthesized compounds were determined by 1H NMR, 13C NMR, and HRMS, and compound 9n was characterized by single-crystal X-ray diffraction. Primary structure–activity relationships (SAR) have also been established.
    Medicinal Chemistry Research 08/2012; 22(8). DOI:10.1007/s00044-012-0400-8 · 1.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This review presents a comprehensive assessment of the synthetic utility of n-perfluoroalkyl iodides (RFI, CnF2n+1-I, where n = 2–14) in the published literature from 2000 through 2010. RFI is a versatile synthetic reagent widely utilized to introduce the perfluoroalkyl functionality and its unique functional characteristics into organic substances. Two distinct analysis tools were employed. First, Reaxys® was employed to examine the versatility and occurrences of RFI in 1356 non-polymeric synthetic transformations. The most common RFI synthetic conversions were (i) free-radical addition to carbon–carbon double or triple bonds, (ii) coupling to aryl halides, and (iii) Grignard, organolithium, or similar RF anion addition to ketones and aldehydes. RFI were also used as a chain transfer reagent in free-radical polymerization reactions of fluorinated and other unsaturated monomers. Second, a complementary Chemical Abstracts’ STN AnaVist® search was employed to summarize the 779 publications describing reaction products that contained n-perfluoroalkyl chains (CnF2n+1-, where n = 2–4). The most common uses for materials into which RFI was incorporated were surfactants, pesticides, electronic materials, pharmaceuticals, liquid crystals, dyes and optical materials, battery electrolytes, repellents, lubricants and polymerization catalysts.
    Journal of Fluorine Chemistry 06/2012; 138:3–23. DOI:10.1016/j.jfluchem.2012.03.011 · 1.95 Impact Factor
Show more